Hemostats Market is expected to reach USD 5.32 billion by 2032 | Major key players - Integralife Lifesciences, Artivion, Medesy.

Market Size and Growth:

The Global Hemostats Market size reached USD 3.11 billion in 2024 and is expected to reach USD 5.32 billion by 2032, growing with a CAGR of 6.9% during the forecast period 2025-2032. The Market Growth is growing due to the rising number of surgical procedures worldwide and increasing adoption of advanced wound care products to control bleeding effectively.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/hemostats-market?sz

The Hemostats Market refers to the global industry focused on products and devices used to control bleeding during surgical procedures. These agents, including mechanical, absorbable, and combination hemostats, help achieve hemostasis efficiently. The market growth is driven by increasing surgical volumes, trauma cases, and advancements in minimally invasive surgical technologies worldwide.

Industry Recent Developments: United States

✅ August 2025: Leading medical device firms introduced advanced flowable hemostats incorporating rapid clotting agents to improve surgical efficiency, particularly for trauma and cardiac procedures.

✅ September 2025: The FDA cleared a new cellulose-based flowable hemostat with enhanced biocompatibility designed for minimally invasive surgeries, facilitating faster patient recovery.

✅ October 2025: The U.S. Hemostats market size is projected to grow steadily, driven by rising surgical procedures, technological advancements, AI integration for surgical decision-making, and FDA breakthrough device designations enhancing clinical outcomes.

Industry Recent Developments: Japan

✅ August 2025: The Japan Hemostats market continues to grow, propelled by the increasing aging population and the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which escalate surgical interventions requiring hemostat usage.

✅ September 2025: Market innovation includes the launch of advanced matrix and gel hemostats, favored for their compatibility and cost-effectiveness in controlling surgical bleeding, especially in orthopedic procedures.

✅ October 2025: Hospitals and clinics lead in hemostat adoption in Japan, with ambulatory surgical centers expected to exhibit rapid growth; combination hemostats are seeing the fastest market expansion among product types.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hemostats-market?sz

FDA Approvals / PMA/clearances in 2025:

✅ Ethicon (Johnson & Johnson) - PMA supplement decision (SURGICEL family)
A PMA supplement for Ethicon's SURGICEL absorbable hemostat devices shows a decision date of March 5, 2025 on the FDA PMA database (PMA N12159, supplement S112).

✅ Note: the PMA entry is a primary FDA record - it indicates a formal PMA supplement decision (the PMA database entry itself should be consulted for the exact scope of the supplement and labeled indications).

Mergers & Acquisitions in 2025:

✅ Merit Medical Systems - acquisition of BioLife Delaware, LLC (Merit announced the acquisition effective May 20, 2025). BioLife/ BioLife Delaware is a maker of hemostatic device products; the deal brings those hemostasis products into Merit's portfolio.

✅ (Context - older but market-relevant deals referenced in industry reports) Integra's acquisition of Surgical Innovation Associates (SIA) was announced in December 2022 (often cited in 2025 market reports as a consolidation example). I list it only as background consolidation context, not a 2025 transaction.

Other Regulatory / market events in 2025 (CE/market launches, withdrawals, regulatory notes):

✅ Baxter - Hemopatch (room-temperature version) launch in Europe (April 2025)
Baxter announced the room-temperature Hemopatch Sealing Hemostat product evolution and availability throughout Europe (press release dated April 10, 2025). This is a regional (Europe) regulatory/market availability announcement rather than a new U.S. FDA clearance.

✅ ABS (an endoscopic topical hemostat) - CE status noted (2025 guidance)
The European Society of Gastrointestinal Endoscopy (ESGE) guideline/documentation notes that ABS (anabasis/plant-derived topical agent discussed in literature) had CE certification but had not (at that time of the guidance) received EMA approval - i.e., available in several European countries under CE marking. This illustrates the split between CE availability and centralized EMA approval pathways.

✅ PMA withdrawal recorded (regulatory action) - Datascope PMA record shows "Withdrawal Date" 28-Feb-2025
The FDA PMA database shows a record for an absorbable collagen hemostat (PMA P850023) with a withdrawal date of February 28, 2025 - a regulatory event to note (product-level regulatory status change). (See the PMA entry for details on reason/scope.)

Major Key Players:

Integralife Lifesciences
Artivion
Medesy
World Precision Instruments
Agnthos
GerMed USA
Burtons Veterinary
Prodent USA
Thermo Fisher Scientific Inc.
Bausch & Lomb Incorporated.

Segments Covered in the Hemostats Market:

By Product type: Halstead mosquito hemostatic forceps, Helly and Crile hemostatic forceps, Rochester-carmalt hemostatic forceps, Others.

By Application: Cardiovascular surgery, General surgery, Gynecological surgery, Reconstructive surgery, Neurological surgery, Orthopedic surgery, Others.

By End User: Hospitals, Ambulatory Surgical Centers, Others.

Regional Analysis for Hemostats Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=hemostats-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Hemostats market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Hemostats Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Hemostats market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Hemostats Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Hemostats market?

➠ Who are the global key manufacturers of the Hemostats Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Hemostats market opportunities and threats faced by the vendors in the global Hemostats Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Hemostats market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.